Analysis of the Structure, Transcripts, and Protein Products of Bcl-2, the Gene Involved in Human Follicular Lymphoma

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1986 Jul 1

PMID 3523487

Citations 213

Authors

Y Tsujimoto

C M Croce

Affiliations

Soon will be listed here.

Abstract

We have determined that the bcl-2 (B-cell leukemia/lymphoma 2) gene is transcribed into three overlapping mRNAs, and we have cloned bcl-2 cDNA sequences. Sequence analysis of the bcl-2 cDNA clones and comparison of their sequences to their genomic counterparts indicate that the bcl-2 gene contains at least two exons. The three bcl-2 transcripts, which are 8.5, 5.5, and 3.5 kilobases (kb) long, overlap within the first exon, but only the 8.5-kb and 5.5-kb transcripts contain sequences of the second exon. The 8.5-kb and 5.5-kb transcripts seem to use different polyadenylylation sites. Sequence analysis of the cDNA clones corresponding to the 5.5-kb and 3.5-kb mRNAs indicates that the two bcl-2 transcripts carry two overlapping open reading frames, one of which is 717 nucleotides long and codes for a protein (bcl-2 alpha) of 239 amino acids and a molecular mass of 26 kDa, while the other codes for a protein of 205 amino acids (bcl-2 beta, molecular mass 22 kDa) that is identical to bcl-2 alpha except at the carboxyl terminus. The bcl-2 protein products in follicular lymphomas with or without bcl-2 rearrangements are identical to the normal bcl-2 products.

Citing Articles

Bcl-2 and Bcl-xL in Diabetes: Contributions to Endocrine Pancreas Viability and Function.

Perez-Serna A, Guzman-Llorens D, Dos Santos R, Marroqui L Biomedicines. 2025; 13(1).

PMID: 39857806 PMC: 11760435. DOI: 10.3390/biomedicines13010223.

Raptinal: a powerful tool for rapid induction of apoptotic cell death.

Smith A, Hergenrother P Cell Death Discov. 2024; 10(1):371.

PMID: 39164225 PMC: 11335860. DOI: 10.1038/s41420-024-02120-1.

Exploring the DNA-PNA heterotriplex formation in targeting the Bcl-2 gene promoter: A structural insight by physico-chemical and microsecond-scale MD investigation.

Falanga A, Lupia A, Tripodi L, Morgillo C, Moraca F, Roviello G Heliyon. 2024; 10(3):e24599.

PMID: 38317891 PMC: 10839560. DOI: 10.1016/j.heliyon.2024.e24599.

The BCL2 inhibitor venetoclax mediates anticancer effects through dendritic cell activation.

Liu P, Zhao L, Zitvogel L, Kepp O, Kroemer G Cell Death Differ. 2023; 30(12):2447-2451.

PMID: 37845384 PMC: 10733328. DOI: 10.1038/s41418-023-01232-y.

NELFA and BCL2 induce the 2C-like state in mouse embryonic stem cells in a chemically defined medium.

Wu B, Wang Y, Wei X, Zhang J, Wu J, Cao G Cell Prolif. 2023; 57(2):e13534.

PMID: 37592709 PMC: 10849787. DOI: 10.1111/cpr.13534.

References

Aviv H, Leder P . Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci U S A. 1972; 69(6):1408-12. PMC: 426713. DOI: 10.1073/pnas.69.6.1408. View

Tan K, Croce C . Transcriptional control of the expression of mouse globin genes in myeloma x erythroleukemia cell hybrids. Somatic Cell Genet. 1982; 8(2):151-61. DOI: 10.1007/BF01538674. View

SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View

Van Den Berghe H, Parloir C, David G, Michaux J, SOKAL G . A new characteristic karyotypic anomaly in lymphoproliferative disorders. Cancer. 1979; 44(1):188-95. DOI: 10.1002/1097-0142(197907)44:1<188::aid-cncr2820440131>3.0.co;2-f. View

Croce C, Shander M, Martinis J, Cicurel L, DAncona G, Dolby T . Chromosomal location of the genes for human immunoglobulin heavy chains. Proc Natl Acad Sci U S A. 1979; 76(7):3416-9. PMC: 383836. DOI: 10.1073/pnas.76.7.3416. View

Ricciardi R, Miller J, Roberts B . Purification and mapping of specific mRNAs by hybridization-selection and cell-free translation. Proc Natl Acad Sci U S A. 1979; 76(10):4927-31. PMC: 413051. DOI: 10.1073/pnas.76.10.4927. View

Thomas P . Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci U S A. 1980; 77(9):5201-5. PMC: 350025. DOI: 10.1073/pnas.77.9.5201. View

Nowell P, Shankey T, Finan J, GUERRY D, Besa E . Proliferation, differentiation, and cytogenetics of chronic leukemic B lymphocytes cultured with mitomycin-treated normal cells. Blood. 1981; 57(3):444-51. View

Yunis J, Oken M, Kaplan M, Ensrud K, Howe R, Theologides A . Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. N Engl J Med. 1982; 307(20):1231-6. DOI: 10.1056/NEJM198211113072002. View

10.

Erikson J, Finan J, Nowell P, Croce C . Translocation of immunoglobulin VH genes in Burkitt lymphoma. Proc Natl Acad Sci U S A. 1982; 79(18):5611-5. PMC: 346954. DOI: 10.1073/pnas.79.18.5611. View

11.

Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo R, Croce C . Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A. 1982; 79(24):7824-7. PMC: 347441. DOI: 10.1073/pnas.79.24.7824. View

12.

Young R, Davis R . Efficient isolation of genes by using antibody probes. Proc Natl Acad Sci U S A. 1983; 80(5):1194-8. PMC: 393560. DOI: 10.1073/pnas.80.5.1194. View

13.

Nishikura K, Erikson J, Watt R, Rovera G, Croce C . Differential expression of the normal and of the translocated human c-myc oncogenes in B cells. Proc Natl Acad Sci U S A. 1983; 80(15):4822-6. PMC: 384137. DOI: 10.1073/pnas.80.15.4822. View

14.

Croce C, Thierfelder W, Erikson J, Nishikura K, Finan J, Lenoir G . Transcriptional activation of an unrearranged and untranslocated c-myc oncogene by translocation of a C lambda locus in Burkitt. Proc Natl Acad Sci U S A. 1983; 80(22):6922-6. PMC: 390098. DOI: 10.1073/pnas.80.22.6922. View

15.

Gubler U, HOFFMAN B . A simple and very efficient method for generating cDNA libraries. Gene. 1983; 25(2-3):263-9. DOI: 10.1016/0378-1119(83)90230-5. View

16.

Van Den Berghe H, Vermaelen K, Louwagie A, Criel A, Mecucci C, Vaerman J . High incidence of chromosome abnormalities in IgG3 myeloma. Cancer Genet Cytogenet. 1984; 11(4):381-7. DOI: 10.1016/0165-4608(84)90017-7. View

17.

Erikson J, Nishikura K, Finan J, Emanuel B, Lenoir G, Nowell P . Translocation of an immunoglobulin kappa locus to a region 3' of an unrearranged c-myc oncogene enhances c-myc transcription. Proc Natl Acad Sci U S A. 1983; 80(24):7581-5. PMC: 534384. DOI: 10.1073/pnas.80.24.7581. View

18.

Nishikura K, Erikson J, DeJesus E, DUGAN D, Croce C . Repression of rearranged mu gene and translocated c-myc in mouse 3T3 cells X Burkitt lymphoma cell hybrids. Science. 1984; 224(4647):399-402. DOI: 10.1126/science.6424234. View

19.

Yunis J, Oken M, Theologides A, HOWE R, Kaplan M . Recurrent chromosomal defects are found in most patients with non-Hodgkin's-lymphoma. Cancer Genet Cytogenet. 1984; 13(1):17-28. DOI: 10.1016/0165-4608(84)90084-0. View

20.

Tsujimoto Y, Finger L, Yunis J, Nowell P, Croce C . Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science. 1984; 226(4678):1097-9. DOI: 10.1126/science.6093263. View